Science Explorer Interactive view Map
Company · Washington D.C. · United States

Oncovir (United States)

oncovir.comROR OpenAlex
Research works
41
▼ 52% vs 2013–17
Citations
2.8k
68.0 per fractional work
Top-10% rate
29.9%
record average 16.5%
Open access
59%
world 28%

Not ranked overall: Oncovir (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Oncovir (United States)?

Ranked on the composite score, Andres Μ. Salazar lead among researchers whose main affiliation is Oncovir (United States).

  1. 1 Andres Μ. Salazar United States · #595,149 worldwide 114 citations · 33 works
All ranked researchers at Oncovir (United States)

Which keywords describe research at Oncovir (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunity, Antigen Presentation, Innate Immunity, Cancer Immunotherapy, Dendritic Cells, Tumor Antigen, Epidemiology and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunity8▲ 56×7 topics
  2. Antigen Presentation8▲ 183×2 topics
  3. Innate Immunity7▲ 51×6 topics
  4. Cancer Immunotherapy7▲ 126×2 topics
  5. Dendritic Cells6▲ 127×1 topic
  6. Tumor Antigen6▲ 179×1 topic
  7. Epidemiology6▲ 3.6×24 topics
  8. Inflammation4▲ 4.1×13 topics
  9. Immunotherapy4▲ 14×12 topics
  10. Vaccine3▲ 20×8 topics
  11. Immune Response3▲ 11×11 topics
  12. Tumor Microenvironment3▲ 20×4 topics
  13. Immune Checkpoint Blockade3▲ 115×1 topic
  14. PD-1 and PD-L13▲ 115×1 topic
  15. Pattern Recognition Receptors3▲ 45×2 topics
  16. Gene Therapy3▲ 24×3 topics
  17. Pathogenesis3▲ 11×6 topics
  18. Pandemic2▲ 12×4 topics
  19. Cancer2▲ 3.8×13 topics
  20. Cytokine-Mediated Link2▲ 65×1 topic
  21. Innate Antiviral Responses2▲ 65×1 topic
  22. Toll-like Receptors2▲ 27×2 topics
  23. Tumor Regression2▲ 54×2 topics
  24. Antibodies2▲ 47×2 topics
  25. Lymphoma2▲ 27×3 topics
  26. Epitope Prediction2▲ 200×1 topic
  27. Peptide-MHC Binding2▲ 200×1 topic
  28. Leukemia2▲ 55×2 topics
  29. RNA Interference2▲ 33×1 topic
  30. siRNA Delivery2▲ 48×1 topic
  31. Mutation1▲ 20×2 topics
  32. NK Cell Recognition1▲ 30×1 topic
  33. Natural Killer Cells1▲ 30×1 topic
  34. ACE2 Receptor1▲ 24×2 topics
  35. CAR T Cells1▲ 69×1 topic
  36. Chimeric Antigen Receptor1▲ 69×1 topic
  37. SARS-CoV-21▲ 19×2 topics
  38. Viral Infection1▲ 41×2 topics
  39. Viral Transmission1▲ 30×2 topics
  40. Tumor Targeting1▲ 21×3 topics

Which research topics does Oncovir (United States) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Mosquito-borne diseases and control.

Immunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksMosquito-borne diseases …0Mosquito-borne diseases and control: 0 fractional worksvaccines and immunoinfor…0vaccines and immunoinformatics approaches: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksCell Adhesion Molecules Research: 0 fractional worksCNS Lymphoma Diagnosis and Treatment: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksImmune cells in cancer: 0 fractional works
ImmunologyOncologyPublic Health, Environmental and Occupational HealthMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  5. 5 vaccines and immunoinformatics approaches Molecular Biology 0 works
  6. 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  7. 7 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  8. 8 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
  9. 9 Autophagy in Disease and Therapy Epidemiology 0 works
  10. 10 Immune cells in cancer Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.6%not open41.4%

World: 28% of research is openly available.

with international co-authors38.9%domestic only61.1%

World: 19% is written across borders.

How has Oncovir (United States)'s research output changed?

Output in 2018–2022 was 52% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Washington D.C.

All research institutions in Washington D.C.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.